Diabetic retinopathy (DR), also known as diabetic eye disease, is when damage occurs to the retina due to diabetes.  It can eventually lead to blindness.

It affects up to 80 percent of people who have had diabetes for 20 years or more.  At least 90% of new cases could be reduced if there were proper treatment and monitoring of the eyes.  The longer a person has diabetes, the higher his or her chances of developing diabetic retinopathy.  Each year in the United States, diabetic retinopathy accounts for 12% of all new cases of blindness.  It is also the leading cause of blindness for people aged 20 to 64 years.

Diabetic retinopathy often has no early warning signs.  Even macular edema, which can cause rapid vision loss, may not have any warning signs for some time.  In general, however, a person with macular edema is likely to have blurred vision, making it hard to do things like read or drive.  In some cases, the vision will get better or worse during the day.

All people with diabetes mellitus are at risk – those with Type I diabetes and those with Type II diabetes.  The longer a person has diabetes, the higher their risk of developing some ocular problem.  Between 40 and 45 percent of Americans diagnosed with diabetes have some stage of diabetic retinopathy.

Up to now, there is no effective drug or medication for diabetic retinopathy on the market.  For the first time in human history, we are proud to announce that DR can be treated and reversed by using our nano-grade eye drops.  During the treatment, optic nerve will be regenerated while capillary occlusion problem will be solved.  This is something that no other eye drops on the market can offer except ours.

All Glory Belongs To God!